Will Kids Get a COVID 19 Vaccine Before the Holidays?
Will Kids Get a COVID-19 Vaccine Before the Holidays? Javascript must be enabled to use this site. Please enable Javascript in your browser and try again. × Search search POPULAR SEARCHES SUGGESTED LINKS Join AARP for just $9 per year when you sign up for a 5-year term. Get instant access to members-only products and hundreds of discounts, a free second membership, and a subscription to AARP the Magazine. Leaving AARP.org Website You are now leaving AARP.org and going to a website that is not operated by AARP. A different privacy policy and terms of service will apply.
AARP Membership — $12 for your first year when you sign up for Automatic Renewal Get instant access to members-only products and hundreds of discounts, a free second membership, and a subscription to AARP the Magazine. shows that hospitalizations among unvaccinated adolescents who are eligible for the shots are 10 times higher compared to their fully vaccinated peers. However, the amount of time taken to test the vaccines in younger populations has been absolutely necessary, Castel says. “In the pediatric world, we always remind people that children are not young adults. They're smaller . Their immune systems are different,” she says. Entertainment $3 off popcorn and soft drink combos See more Entertainment offers > And because children can have more robust immune responses to vaccines, it’s important to monitor their safety and effectiveness in adults first, says Yvonne Maldonado, M.D., an infectious disease expert and professor of pediatrics, epidemiology and population health at Stanford Medicine. “You want to be careful . You want to be paced,” she adds. Experts will be looking closely at one response, in particular: myocarditis, or inflammation of the heart muscle — a rare complication that has popped up in some younger Pfizer and Moderna vaccine recipients and usually resolves quickly with care. Still, health officials say the benefits of the vaccine far outweigh the risks, especially considering myocarditis is more likely to result from a viral infection like COVID-19.
Will Kids Get COVID Vaccines Before the Holidays
Shots for children 5 to 11 could be here this fall but hurdles remain
Getty Images This year’s Thanksgiving may look at lot like last year’s, with scaled-down guest lists, outdoor dinners and requests for family members to bring their masks and the mashed potatoes. A big reason: It’s unlikely that kids under 12 will be fully vaccinated by late November. But the good news is, many could have one of the two shots needed under their belts by then. Experts are hopeful that a two-dose for children ages 5 to 11 from Pfizer-BioNTech will clear regulatory hurdles by the end of October or early November, paving the way for millions more Americans to get vaccinated, at least partially, this fall. And by the December holidays — “if everything occurs as we anticipate and the [authorization] comes in late October” — many children in this age group could be fully protected against COVID, predicts Amanda Castel, M.D., a pediatrician and infectious disease epidemiologist at George Washington University’s Milken School of Public Health. Get instant access to members-only products and hundreds of discounts, a free second membership, and a subscription to AARP the Magazine. Pfizer has submitted data to the Food and Drug Administration (FDA) from its clinical trial testing a smaller-dose vaccine (one-third of the dose adults receive, with 21 days between the first and second dose s) in more than 2,200 5- to 11-year-olds, and says it plans to ask the agency to authorize the product in the coming weeks. Once it does, the FDA and its panel of outside experts will review the data (this typically takes about a month) and decide whether to allow it. The trial results will also be scrutinized by the Centers for Disease Control and Prevention (CDC) and its advisory committee. Data from Pfizer’s vaccine trial looking at kids younger than 5 are expected later this year or early next. Vaccine makers Moderna and Johnson & Johnson are also studying their products in kids and adolescents, but trail behind Pfizer’s timeline.Vaccine can help slow surge in kids cases
The wait for these vaccines has been long for parents, grandparents, teachers and others anxious to keep little ones from becoming infected and spreading the virus to others. And the rise of the , coupled with schools reopening, has only amplified the urgency. Currently, children make up more than a quarter of new COVID-19 cases in the U.S., and hospitalization rates among kids under 12 are the highest they’ve been since the start of the pandemic, . That’s not because the dominant delta variant causes more severe disease in children; it’s because the strain is highly contagious, says Claire Boogaard, M.D., medical director of the COVID-19 vaccine program at Children’s National Hospital in Washington, D.C.AARP Membership — $12 for your first year when you sign up for Automatic Renewal Get instant access to members-only products and hundreds of discounts, a free second membership, and a subscription to AARP the Magazine. shows that hospitalizations among unvaccinated adolescents who are eligible for the shots are 10 times higher compared to their fully vaccinated peers. However, the amount of time taken to test the vaccines in younger populations has been absolutely necessary, Castel says. “In the pediatric world, we always remind people that children are not young adults. They're smaller . Their immune systems are different,” she says. Entertainment $3 off popcorn and soft drink combos See more Entertainment offers > And because children can have more robust immune responses to vaccines, it’s important to monitor their safety and effectiveness in adults first, says Yvonne Maldonado, M.D., an infectious disease expert and professor of pediatrics, epidemiology and population health at Stanford Medicine. “You want to be careful . You want to be paced,” she adds. Experts will be looking closely at one response, in particular: myocarditis, or inflammation of the heart muscle — a rare complication that has popped up in some younger Pfizer and Moderna vaccine recipients and usually resolves quickly with care. Still, health officials say the benefits of the vaccine far outweigh the risks, especially considering myocarditis is more likely to result from a viral infection like COVID-19.